ZOMETA® Patient Case Study–The Clinical Question Addressing Lung Cancer and Patient's Bone Health

View videos on bone
metastases and the ZOMETA
mechanism of action

Learn more about the ZOMETA(zoledronic acid) mechanism of action

For non-U.S. Healthcare Professionals: Get information about ZOMETA and its product characteristics

Learn more about ZOMETA product characteristics

ZOMETA is the current standard of care for the prevention of skeletal-related events (SREs)

ZOMETAŽ Lung Cancer Patient Case Study Anthony

Anthony P.

Aged 64 years
Retired auto mechanic
Quit smoking 10 years ago

How would you address Anthony's bone health?

Anthony's physician has chosen to treat him with bevacizumab in combination with
paclitaxel + carboplatin
Anthony's physician is considering adding ZOMETA^® to his treatment regimen, but is
concerned about Anthony's poor prognosis

Disclaimer: This is an international website for ZOMETA^® (zoledronic acid) and is intended for healthcare professionals outside the US. If you are a US resident, please click on the US Residents link at the top of this page. The information on this site is not country-specific and may contain information that is outside the approved indications in the country in which you are located.